COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2seventy bio, Inc. | COM | 901384107 | 30,013 | 2,062,744 | SH | | SOLE | | 2,062,744 | 0 | 0 |
Aadi Bioscience, Inc. | COM | 00032Q104 | 13,988 | 989,928 | SH | | SOLE | | 989,928 | 0 | 0 |
AbCellera Biologics Inc. | COM | 00288U106 | 103,352 | 10,450,180 | SH | | SOLE | | 10,450,180 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 685,868 | 41,923,486 | SH | | SOLE | | 41,923,486 | 0 | 0 |
Achilles Therapeutics plc | SPONSORED ADS | 00449L102 | 5,856 | 2,591,366 | SH | | SOLE | | 2,591,366 | 0 | 0 |
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 10,568 | 9,830,877 | SH | | SOLE | | 9,830,877 | 0 | 0 |
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 1,794 | 3,410,106 | SH | | SOLE | | 3,410,106 | 0 | 0 |
Aerovate Therapeutics, Inc. | COM | 008064107 | 32,821 | 1,979,568 | SH | | SOLE | | 1,979,568 | 0 | 0 |
Affimed N.V. | COM | N01045108 | 13,589 | 6,596,830 | SH | | SOLE | | 6,596,830 | 0 | 0 |
Akero Therapeutics, Inc. | COM | 00973Y108 | 80,643 | 2,368,378 | SH | | SOLE | | 2,368,378 | 0 | 0 |
Alector, Inc. | COM | 014442107 | 2,263 | 239,228 | SH | | SOLE | | 239,228 | 0 | 0 |
Aligos Therapeutics, Inc. | COM | 01626L105 | 2,284 | 2,076,400 | SH | | SOLE | | 2,076,400 | 0 | 0 |
Alkermes plc | SHS | G01767105 | 18,199 | 815,016 | SH | | SOLE | | 815,016 | 0 | 0 |
Allakos Inc. | COM | 01671P100 | 4,303 | 703,050 | SH | | SOLE | | 703,050 | 0 | 0 |
Altimmune, Inc. | COM | 02155H200 | 22,599 | 1,769,681 | SH | | SOLE | | 1,769,681 | 0 | 0 |
Amarin Corporation plc | SPONSORED ADR | 023111206 | 5,861 | 5,377,113 | SH | | SOLE | | 5,377,113 | 0 | 0 |
AnaptysBio, Inc. | COM | 032724106 | 10,897 | 427,179 | SH | | SOLE | | 427,179 | 0 | 0 |
argenx SE | SPONSORED ADR | 04016X101 | 98,910 | 280,159 | SH | | SOLE | | 280,159 | 0 | 0 |
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 501,085 | 4,852,655 | SH | | SOLE | | 4,852,655 | 0 | 0 |
Atara Biotherapeutics, Inc. | COM | 046513107 | 2,813 | 744,186 | SH | | SOLE | | 744,186 | 0 | 0 |
Athira Pharma, Inc. | COM | 04746L104 | 3,091 | 1,040,834 | SH | | SOLE | | 1,040,834 | 0 | 0 |
Atreca, Inc. | CL A COM | 04965G109 | 5,546 | 3,532,760 | SH | | SOLE | | 3,532,760 | 0 | 0 |
aTyr Pharma, Inc. | COM | 002120202 | 604 | 201,361 | SH | | SOLE | | 201,361 | 0 | 0 |
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 1,573,201 | 11,668,897 | SH | | SOLE | | 11,668,897 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 299 | 249,123 | SH | | SOLE | | 249,123 | 0 | 0 |
Bicycle Therapeutics plc | SPONSORED ADS | 088786108 | 19,627 | 843,814 | SH | | SOLE | | 843,814 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 160,156 | 12,710,818 | SH | | SOLE | | 12,710,818 | 0 | 0 |
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 645,989 | 7,620,494 | SH | | SOLE | | 7,620,494 | 0 | 0 |
Biomea Fusion, Inc. | COM | 09077A106 | 20,583 | 2,104,559 | SH | | SOLE | | 2,104,559 | 0 | 0 |
bluebird bio, Inc. | COM | 09609G100 | 15,823 | 2,499,715 | SH | | SOLE | | 2,499,715 | 0 | 0 |
Cabaletta Bio, Inc. | COM | 12674W109 | 430 | 662,063 | SH | | SOLE | | 662,063 | 0 | 0 |
Century Therapeutics, Inc. | COM | 15673T100 | 3,665 | 370,587 | SH | | SOLE | | 370,587 | 0 | 0 |
Cerus Corporation | COM | 157085101 | 57,843 | 16,067,558 | SH | | SOLE | | 16,067,558 | 0 | 0 |
ChemoCentryx, Inc. | COM | 16383L106 | 92,609 | 1,792,657 | SH | | SOLE | | 1,792,657 | 0 | 0 |
Chinook Therapeutics, Inc. | COM | 16961L106 | 49,820 | 2,534,102 | SH | | SOLE | | 2,534,102 | 0 | 0 |
CinCor Pharma, Inc. | COM | 17240Y109 | 26,493 | 807,212 | SH | | SOLE | | 807,212 | 0 | 0 |
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 14,449 | 735,716 | SH | | SOLE | | 735,716 | 0 | 0 |
CymaBay Therapeutics, Inc. | COM | 23257D103 | 7,597 | 2,170,464 | SH | | SOLE | | 2,170,464 | 0 | 0 |
Cyteir Therapeutics, Inc. | COM | 23284P103 | 5,076 | 2,643,640 | SH | | SOLE | | 2,643,640 | 0 | 0 |
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 25,867 | 14,614,264 | SH | | SOLE | | 14,614,264 | 0 | 0 |
Denali Therapeutics Inc. | COM | 24823R105 | 18,068 | 588,738 | SH | | SOLE | | 588,738 | 0 | 0 |
Design Therapeutics, Inc. | COM | 25056L103 | 24,021 | 1,436,636 | SH | | SOLE | | 1,436,636 | 0 | 0 |
DICE Therapeutics, Inc. | COM | 23345J104 | 11,929 | 588,235 | SH | | SOLE | | 588,235 | 0 | 0 |
Edgewise Therapeutics, Inc. | COM | 28036F105 | 4,920 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
Eiger BioPharmaceuticals, Inc. | COM | 28249U105 | 4,065 | 539,851 | SH | | SOLE | | 539,851 | 0 | 0 |
Entrada Therapeutics, Inc. | COM | 29384C108 | 76,685 | 4,865,819 | SH | | SOLE | | 4,865,819 | 0 | 0 |
Fate Therapeutics, Inc. | COM | 31189P102 | 4,834 | 215,695 | SH | | SOLE | | 215,695 | 0 | 0 |
FibroGen, Inc. | COM | 31572Q808 | 10,612 | 815,718 | SH | | SOLE | | 815,718 | 0 | 0 |
Foghorn Therapeutics Inc. | COM | 344174107 | 386 | 45,027 | SH | | SOLE | | 45,027 | 0 | 0 |
Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | 37,641 | 1,886,760 | SH | | SOLE | | 1,886,760 | 0 | 0 |
Fulgent Genetics, Inc. | COM | 359664109 | 6,352 | 166,619 | SH | | SOLE | | 166,619 | 0 | 0 |
Genetron Holdings Limited | ADS | 37186H100 | 356 | 455,306 | SH | | SOLE | | 455,306 | 0 | 0 |
Global Blood Therapeutics, Inc. | COM | 37890U108 | 254,183 | 3,732,502 | SH | | SOLE | | 3,732,502 | 0 | 0 |
Heron Therapeutics, Inc. | COM | 427746102 | 34,316 | 8,131,678 | SH | | SOLE | | 8,131,678 | 0 | 0 |
HOOKIPA Pharma Inc. | COM | 43906K100 | 3,217 | 2,400,481 | SH | | SOLE | | 2,400,481 | 0 | 0 |
Horizon Therapeutics Public Ltd Co | SHS | G46188101 | 60,016 | 969,727 | SH | | SOLE | | 969,727 | 0 | 0 |
IDEAYA Biosciences, Inc. | COM | 45166A102 | 24,892 | 1,668,355 | SH | | SOLE | | 1,668,355 | 0 | 0 |
IGM Biosciences, Inc. | COM | 449585108 | 71,770 | 3,156,102 | SH | | SOLE | | 3,156,102 | 0 | 0 |
Immatics N.V. | SHS | N44445109 | 44,237 | 4,423,731 | SH | | SOLE | | 4,423,731 | 0 | 0 |
Immunocore Holdings plc | ADS | 45258D105 | 118,323 | 2,520,731 | SH | | SOLE | | 2,520,731 | 0 | 0 |
Incyte Corporation | COM | 45337C102 | 2,409,341 | 36,154,574 | SH | | SOLE | | 36,154,574 | 0 | 0 |
Insmed Incorporated | COM PAR $.01 | 457669307 | 430 | 19,950 | SH | | SOLE | | 19,950 | 0 | 0 |
Instil Bio, Inc. | COM | 45783C101 | 18,846 | 3,893,700 | SH | | SOLE | | 3,893,700 | 0 | 0 |
Invitae Corporation | COM | 46185L103 | 20,669 | 8,402,035 | SH | | SOLE | | 8,402,035 | 0 | 0 |
iTeos Therapeutics, Inc. | COM | 46565G104 | 2,864 | 150,346 | SH | | SOLE | | 150,346 | 0 | 0 |
Kezar Life Sciences, Inc. | COM | 49372L100 | 533 | 61,946 | SH | | SOLE | | 61,946 | 0 | 0 |
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 35,947 | 2,799,577 | SH | | SOLE | | 2,799,577 | 0 | 0 |
Kodiak Sciences Inc. | COM | 50015M109 | 133,983 | 17,310,490 | SH | | SOLE | | 17,310,490 | 0 | 0 |
Kronos Bio, Inc. | COM | 50107A104 | 5,158 | 1,539,616 | SH | | SOLE | | 1,539,616 | 0 | 0 |
Krystal Biotech, Inc. | COM | 501147102 | 29,426 | 422,185 | SH | | SOLE | | 422,185 | 0 | 0 |
Kymera Therapeutics, Inc. | COM | 501575104 | 62,694 | 2,879,825 | SH | | SOLE | | 2,879,825 | 0 | 0 |
Leap Therapeutics, Inc. | COM | 52187K101 | 493 | 559,705 | SH | | SOLE | | 559,705 | 0 | 0 |
LogicBio Therapeutics, Inc. | COM | 54142F102 | 38 | 139,105 | SH | | SOLE | | 139,105 | 0 | 0 |
MacroGenics, Inc. | COM | 556099109 | 3,088 | 892,579 | SH | | SOLE | | 892,579 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 97,434 | 1,499,213 | SH | | SOLE | | 1,499,213 | 0 | 0 |
Mirati Therapeutics, Inc. | COM | 60468T105 | 98,459 | 1,409,784 | SH | | SOLE | | 1,409,784 | 0 | 0 |
Natera, Inc. | COM | 632307104 | 4,382 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 2,446 | 3,821,740 | SH | | SOLE | | 3,821,740 | 0 | 0 |
Nkarta, Inc. | COM | 65487U108 | 5,264 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Nurix Therapeutics, Inc. | COM | 67080M103 | 50,584 | 3,882,125 | SH | | SOLE | | 3,882,125 | 0 | 0 |
Opthea Limited | SPONSORED ADS | 68386J208 | 16,687 | 2,691,391 | SH | | SOLE | | 2,691,391 | 0 | 0 |
Otonomy, Inc. | COM | 68906L105 | 2,491 | 8,443,134 | SH | | SOLE | | 8,443,134 | 0 | 0 |
Pacific Biosciences of California, Inc. | COM | 69404D108 | 6,547 | 1,127,782 | SH | | SOLE | | 1,127,782 | 0 | 0 |
PMV Pharmaceuticals, Inc. | COM | 69353Y103 | 3,832 | 322,024 | SH | | SOLE | | 322,024 | 0 | 0 |
POINT Biopharma Global Inc. | COM | 730541109 | 9,037 | 1,169,103 | SH | | SOLE | | 1,169,103 | 0 | 0 |
Prelude Therapeutics Inc. | COM | 74065P101 | 66,918 | 10,123,824 | SH | | SOLE | | 10,123,824 | 0 | 0 |
Protara Therapeutics, Inc. | COM STK | 74365U107 | 591 | 199,671 | SH | | SOLE | | 199,671 | 0 | 0 |
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 5,629 | 223,976 | SH | | SOLE | | 223,976 | 0 | 0 |
Relmada Therapeutics, Inc. | COM | 75955J402 | 18,329 | 495,113 | SH | | SOLE | | 495,113 | 0 | 0 |
Replimune Group, Inc. | COM | 76029N106 | 67,247 | 3,893,843 | SH | | SOLE | | 3,893,843 | 0 | 0 |
Revolution Medicines, Inc. | COM | 76155X100 | 4,382 | 222,222 | SH | | SOLE | | 222,222 | 0 | 0 |
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 148,536 | 6,062,702 | SH | | SOLE | | 6,062,702 | 0 | 0 |
Seagen Inc. | COM | 81181C104 | 6,419,005 | 46,912,266 | SH | | SOLE | | 46,912,266 | 0 | 0 |
Sera Prognostics, Inc. | CLASS A COM | 81749D107 | 322 | 201,562 | SH | | SOLE | | 201,562 | 0 | 0 |
Stoke Therapeutics, Inc. | COM | 86150R107 | 4,742 | 369,327 | SH | | SOLE | | 369,327 | 0 | 0 |
Surrozen, Inc. | COM | 86889P109 | 5,050 | 2,500,000 | SH | | SOLE | | 2,500,000 | 0 | 0 |
Surrozen, Inc. | W EXP 8/11/2026 | 86889P117 | 154 | 833,333 | SH | | SOLE | | 833,333 | 0 | 0 |
Syndax Pharmaceuticals, Inc. | COM | 87164F105 | 2,661 | 110,729 | SH | | SOLE | | 110,729 | 0 | 0 |
Talis Biomedical Corporation | COM | 87424L108 | 5,197 | 7,624,835 | SH | | SOLE | | 7,624,835 | 0 | 0 |
Tango Therapeutics, Inc. | COM | 87583X109 | 2,715 | 750,000 | SH | | SOLE | | 750,000 | 0 | 0 |
TCR2 Therapeutics Inc. | COM | 87808K106 | 1,356 | 753,064 | SH | | SOLE | | 753,064 | 0 | 0 |
Travere Therapeutics, Inc. | COM | 89422G107 | 81,312 | 3,300,009 | SH | | SOLE | | 3,300,009 | 0 | 0 |
Tricida, Inc. | COM | 89610F101 | 13,837 | 1,320,290 | SH | | SOLE | | 1,320,290 | 0 | 0 |
TScan Therapeutics, Inc. | COM | 89854M101 | 8,494 | 2,784,792 | SH | | SOLE | | 2,784,792 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 19,503 | 470,974 | SH | | SOLE | | 470,974 | 0 | 0 |
Vera Therapeutics, Inc. | CL A | 92337R101 | 7,103 | 333,333 | SH | | SOLE | | 333,333 | 0 | 0 |
Verastem, Inc. | COM | 92337C104 | 22,941 | 26,988,898 | SH | | SOLE | | 26,988,898 | 0 | 0 |
Verve Therapeutics, Inc. | COM | 92539P101 | 48,658 | 1,416,530 | SH | | SOLE | | 1,416,530 | 0 | 0 |
Veru Inc. | COM | 92536C103 | 18,542 | 1,609,579 | SH | | SOLE | | 1,609,579 | 0 | 0 |
Vincerx Pharma, Inc. | COM | 92731L106 | 333 | 241,379 | SH | | SOLE | | 241,379 | 0 | 0 |
Vor Biopharma Inc. | COM | 929033108 | 5,834 | 1,465,925 | SH | | SOLE | | 1,465,925 | 0 | 0 |
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 27,134 | 751,639 | SH | | SOLE | | 751,639 | 0 | 0 |
Zymeworks Inc. | COM | 98985W102 | 10,507 | 1,708,472 | SH | | SOLE | | 1,708,472 | 0 | 0 |
Insmed Incorporated | Note 0.75% 6/1/2028 | 457669AB5 | 36,296 | 40,000,000 | PRN | | SOLE | | 40,000,000 | 0 | 0 |
Invitae Corporation | Note 2.0% 9/1/2024 | 46185LAB9 | 8,148 | 10,300,000 | PRN | | SOLE | | 10,300,000 | 0 | 0 |